FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.22-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

1268918002: Pancreatic protease (substance)


Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Mar 2023. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
5181930012 Pancreatic protease (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
5181931011 Pancreatic protease en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core


4 descendants. Search Descendants:

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Pancreatic protease (substance) Is a Pancreatic enzyme (substance) true Inferred relationship Some
Pancreatic protease (substance) Is a Hydrolase true Inferred relationship Some
Pancreatic protease (substance) Is a Protein true Inferred relationship Some
Pancreatic protease (substance) This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. Hydrolase (disposition) true Inferred relationship Some
Pancreatic protease (substance) This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. Pancreatic enzyme (disposition) true Inferred relationship Some

Inbound Relationships Type Active Source Characteristic Refinability Group
Chymotrypsin Is a True Pancreatic protease (substance) Inferred relationship Some
Trypsin Is a True Pancreatic protease (substance) Inferred relationship Some
Chymotrypsin C Is a True Pancreatic protease (substance) Inferred relationship Some
Product containing precisely pancreatic amylase 8000 unit and pancreatic lipase 10000 unit and pancreatic protease 600 unit/1 each gastro-resistant oral capsule (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Pancreatic protease (substance) Inferred relationship Some 1
Product containing precisely pancreatic amylase 8000 unit and pancreatic lipase 10000 unit and pancreatic protease 600 unit/1 each gastro-resistant oral capsule (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Pancreatic protease (substance) Inferred relationship Some 1
Product containing precisely pancreatic amylase 18000 unit and pancreatic lipase 25000 unit and pancreatic protease 1000 unit/1 each gastro-resistant oral capsule (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Pancreatic protease (substance) Inferred relationship Some 1
Product containing precisely pancreatic amylase 18000 unit and pancreatic lipase 25000 unit and pancreatic protease 1000 unit/1 each gastro-resistant oral capsule (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Pancreatic protease (substance) Inferred relationship Some 1
Pancreatic amylase and pancreatic lipase and pancreatic protease only product in oral dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Pancreatic protease (substance) Inferred relationship Some 1
Pancreatic amylase and pancreatic lipase and pancreatic protease only product The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Pancreatic protease (substance) Inferred relationship Some 1
Product containing pancreatic amylase and pancreatic lipase and pancreatic protease in oral dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Pancreatic protease (substance) Inferred relationship Some 1
Pancreatic amylase- and pancreatic lipase- and pancreatic protease-containing product The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Pancreatic protease (substance) Inferred relationship Some 1
Product containing precisely pancreatic amylase 36 unit/1 milligram and pancreatic lipase 50 unit/1 milligram and pancreatic protease 2 unit/1 milligram gastro-resistant oral granules (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Pancreatic protease (substance) Inferred relationship Some 1
Product containing precisely pancreatic amylase 36 unit/1 milligram and pancreatic lipase 50 unit/1 milligram and pancreatic protease 2 unit/1 milligram gastro-resistant oral granules (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Pancreatic protease (substance) Inferred relationship Some 1
Pancreatic amylase 16000 unit and pancreatic lipase 20000 unit and pancreatic protease 1200 unit gastro-resistant oral capsule The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Pancreatic protease (substance) Inferred relationship Some 1
Pancreatic amylase 16000 unit and pancreatic lipase 20000 unit and pancreatic protease 1200 unit gastro-resistant oral capsule This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Pancreatic protease (substance) Inferred relationship Some 1

This concept is not in any reference sets

Back to Start